Applera Corporation is comprised of three dynamic businesses that make a vital contribution to the human condition by developing advanced analytical tools…discovering and developing new drugs and identifying new therapeutic targets …and creating diagnostic solutions.

These businesses-Applied Biosystems, Celera Genomics and Celera Diagnostics-provide a wealth of opportunities to scientists and health care professionals who want to be at the forefront of technological advancements in the effort to diagnose and treat diseases.

Applied Biosystems
Applied Biosystems is a market leader in the development, manufacture, sale and support of a wide variety of instrument-based systems, reagents and software that have made a significant contribution to our understanding of the molecular foundations of life.

Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries, leading to the development of new pharmaceuticals and to conduct standardized testing.s

Celera Genomics
The Celera Genomics Group, located in Rockville, MD, and South San Francisco, CA, is engaged principally in integrating advanced technologies to discover and develop new therapeutics. Celera intends to leverage its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets and diagnostic marker candidates, and to discover and develop new therapeutics. Its Celera Discovery System™ online platform, marketed exclusively through the Applied Biosystems Knowledge Business , is an integrated source of information based on the human genome and other biological and medical sources.

Celera Diagnostics
Celera Diagnostics has been established as a 50/50 joint venture between Applied Biosystems and Celera Genomics. This new venture is focused on discovery, development and commercialization of novel diagnostic tests.

Headquartered in Alameda, CA, Celera Diagnostics focuses on discovering novel genetic markers for disease and configuring these into new diagnostic tests to predict, characterize, monitor and select therapy for cardiovascular disease, auto-immunity, central nervous system disorders, and cancer.

www.applera.com